Porous Scaffolds Support Extrahepatic Human Islet Transplantation, Engraftment, and Function in Mice
Islet transplantation as a therapy or cure for type 1 diabetes has significant promise but has been limited by islet mass requirements and long-term graft failure. The intrahepatic and intravascular site may be responsible for significant loss of transplanted islets. Nonencapsulating biomaterial sca...
Main Authors: | Romie F. Gibly, Xiaomin Zhang, William L. Lowe, Lonnie D. Shea |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X636966 |
Similar Items
-
Microwell scaffolds for the extrahepatic transplantation of islets of Langerhans.
by: Mijke Buitinga, et al.
Published: (2013-01-01) -
Macroporous Three-Dimensional PDMS Scaffolds for Extrahepatic Islet Transplantation
by: Eileen Pedraza, et al.
Published: (2013-07-01) -
Islet Engraftment and Revascularization in Clinical and Experimental Transplantation
by: Christian Molnár, et al.
Published: (2013-02-01) -
Secretory Unit of Islet in Transplantation (SUIT) and Engrafted Islet Rate (EIR) Indexes Are Useful for Evaluating Single Islet Transplantation
by: Hirofumi Noguchi, et al.
Published: (2008-01-01) -
Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice
by: Suzanne Bertera, et al.
Published: (2021-04-01)